Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Completed · Phase 3

Conditions studied: Cervical Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for cervical cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of three different chemotherapy regimens in treating patients with stage IVB, recurrent, or persistent cervical cancer.

Key facts

Study ID

NCT00003945

Run by

Gynecologic Oncology Group

People needed

400

Starts

1999-06-01

Last updated by the study team

2013-05-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Indiana University Cancer Center — Indianapolis, Indiana, United States
• John Stoddard Cancer Center at Iowa Methodist Medical Center — Des Moines, Iowa, United States
• Mercy Cancer Center at Mercy Medical Center-Des Moines — Des Moines, Iowa, United States
• Iowa Lutheran Hospital — Des Moines, Iowa, United States
• Midlands Cancer Center at Midlands Community Hospital — Papillion, Nebraska, United States
• MBCCOP - University of New Mexico HSC — Albuquerque, New Mexico, United States
• Penn State Cancer Institute at Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
• CCOP - St. Vincent Hospital Cancer Center, Green Bay — Green Bay, Wisconsin, United States
• Westmead Hospital — Westmead, New South Wales, Australia
• Instituto de Enfermedades Neoplasicas — Lima, Peru
• San Juan City Hospital — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.